Analyst Ratings for Ocular Therapeutix (OCUL)
OCUL Rating Summary
OCUL Price Target Summary
- Highest: $34.00 (Citizens)
- Lowest: $14.00 (UBS)
- Average: $25.22
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$25.22 (+267.1%)
* Over Last 12-Mos
Rating Score: 9.5 / 10
Percentile Rank: 91%
Avg. $ Target:
$25.22 (+267.1%)
* Over Last 12-Mos
Rating Score: 9.5 / 10
Percentile Rank: 91%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | UBS | Alice Nettleton | New Coverage | Buy (N/A) |
14.00 (N/A) |
7.51 (6.87) |
-8.52% | Details |
| 9/15/2025 | Chardan | Daniil Gataulin | New Coverage | Buy (N/A) |
21.00 (N/A) |
12.81 (6.87) |
-46.37% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
